CompletedPhase 3NCT00003328
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Studying Squamous cell carcinoma of oral cavity and lip
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boehringer Ingelheim
- Principal Investigator
- Peter M. Glassman, MD, PhDBoehringer Ingelheim
- Intervention
- porfiromycin(drug)
- Enrollment
- 600 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1997
Study locations (4)
- Veterans Affairs Medical Center - Washington, DC, Washington D.C., District of Columbia, United States
- Health Advance Institute, Peoria, Illinois, United States
- Simmons Cancer Center - Dallas, Dallas, Texas, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003328 on ClinicalTrials.govOther trials for Squamous cell carcinoma of oral cavity and lip
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07195734Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerNational Cancer Institute (NCI)
- RECRUITINGNANCT07264036Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot StudyVanessa Torrecillas
- RECRUITINGPHASE2NCT07121595Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialUniversity of Michigan Rogel Cancer Center
- RECRUITINGNCT05837221Microbiome in Head and Neck Squamous Cell CarcinomaUniversity of Colorado, Denver
- RECRUITINGPHASE2NCT05576974A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)University of Texas Southwestern Medical Center
- RECRUITINGPHASE1, PHASE2NCT06265025GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsGeneMedicine Co., Ltd.
- RECRUITINGNANCT05811936The SNAP Tool for Head and Neck Cancer Survivor-Caregiver DyadsMedical University of South Carolina
- ACTIVE NOT RECRUITINGPHASE1NCT05820711Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation TherapyUniversity of Wisconsin, Madison
See all trials for Squamous cell carcinoma of oral cavity and lip →